Teplizumab preserves C-peptide in recent-onset type 1 diabetes: 2-year results from the randomized, placebo-controlled Protégé trial Running title: 2year results of the Protégé trial

2013 
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    18
    References
    1
    Citations
    NaN
    KQI
    []